Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Aggressive Diabetic Kidney Disease in Youth-Onset Type 2 Diabetes: Pathogenetic Mechanisms and Potential Therapies
Michela Amatruda, Guido Gembillo, Alfio Edoardo Giuffrida, et al.
Medicina (2021) Vol. 57, Iss. 9, pp. 868-868
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Potential Role of Copper in Diabetes and Diabetic Kidney Disease
Guido Gembillo, Vincenzo Labbozzetta, Alfio Edoardo Giuffrida, et al.
Metabolites (2022) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 39
Role of Zinc in Diabetic Kidney Disease
Guido Gembillo, Luca Visconti, Alfio Edoardo Giuffrida, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1353-1353
Open Access | Times Cited: 29
Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy
Vijay Sharma, Manoj Khokhar, Prasanta K. Panigrahi, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119842-119842
Closed Access | Times Cited: 5
Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetes
Suyan Duan, Meng Zhou, Lu Fang, et al.
Endocrine (2023) Vol. 81, Iss. 1, pp. 77-89
Closed Access | Times Cited: 11
IFN-γ, SCF, MIP1b and IL-16 Were Associated with Risk of Diabetic Nephropathy: A Mendelian Randomization Study
Li An, Xiaomei Ren, Ye Pan, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 851-856
Open Access | Times Cited: 4
Predictors of cardio-kidney complications and treatment failure in patients with chronic kidney disease and type 2 diabetes treated with SGLT2 inhibitors
Csaba P. Kövesdy, Niklas Schmedt, Kerstin Folkerts, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Combine Therapy of Gallic Acid and Allicin in Management of Diabetes
Roshan Kumar, Prachi Sood, Vinod Rana, et al.
Journal for Research in Applied Sciences and Biotechnology (2023) Vol. 2, Iss. 3, pp. 91-99
Open Access | Times Cited: 10
Glomerular hyperfiltration: part 2—clinical significance in children
Oyindamola C. Adebayo, Agathe B. Nkoy, Lambertus P. van den Heuvel, et al.
Pediatric Nephrology (2022) Vol. 38, Iss. 8, pp. 2529-2547
Closed Access | Times Cited: 15
Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease
Annalisa Bianco, Claudio Tiribelli, Cristina Bellarosa
Biomedicines (2022) Vol. 10, Iss. 3, pp. 696-696
Open Access | Times Cited: 13
Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
Tomislav Bulum
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2586-2586
Open Access | Times Cited: 12
Efficacy and Safety of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist in Real-Life: A Case Series of Patients in Maintenance Incremental Hemodialysis
José C. De La Flor, Javier Deira Lorenzo, Alexander Marschall, et al.
Case Reports in Nephrology and Dialysis (2022) Vol. 12, Iss. 3, pp. 238-247
Open Access | Times Cited: 11
Youth versus adult-onset type 2 diabetic kidney disease: Insights into currently known structural differences and the potential underlying mechanisms
Kalie L. Tommerdahl, Jessica Kendrick, Robert G. Nelson, et al.
Clinical Science (2022) Vol. 136, Iss. 21, pp. 1471-1483
Open Access | Times Cited: 9
The analysis of risk factors for diabetic kidney disease progression: a single-centre and cross-sectional experiment in Shanghai
Wen Liu, Juan Du, Xiaoxu Ge, et al.
BMJ Open (2022) Vol. 12, Iss. 6, pp. e060238-e060238
Open Access | Times Cited: 8
Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank
Seyedeh Forough Sajjadi, Julian W. Sacre, Bendix Carstensen, et al.
Diabetic Medicine (2024) Vol. 41, Iss. 9
Closed Access | Times Cited: 1
Association of major candidate protein biomarkers and long-term diabetic kidney disease progression among Asians with young-onset type 2 diabetes mellitus
Tan Si Hua Clara, Huili Zheng, Jianjun Liu, et al.
Diabetes Research and Clinical Practice (2024) Vol. 216, pp. 111821-111821
Closed Access | Times Cited: 1
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review
Guido Gembillo, Valeria Cernaro, Alfio Edoardo Giuffrida, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 3, pp. 323-339
Closed Access | Times Cited: 6
Effect of exercise on renal function in diabetic nephropathy—a systematic review and meta-analysis
Megha Nataraj, G. Arun Maiya, Shankar Prasad Nagaraju, et al.
Journal of Taibah University Medical Sciences (2022) Vol. 18, Iss. 3, pp. 526-537
Open Access | Times Cited: 6
Dysregulated coagulation system links to inflammation in diabetic kidney disease
Mengyun Xiao, Donge Tang, Shaodong Luan, et al.
Frontiers in Clinical Diabetes and Healthcare (2023) Vol. 4
Open Access | Times Cited: 3
Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney Disease
Aggeliki Tserga, Despoina Pouloudi, Jean Sébastien Saulnier‐Blache, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 216-216
Open Access | Times Cited: 5
Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor
Tso-Hsiao Chen, Chung‐Yi Cheng, Chun‐Kai Huang, et al.
Microbiology Spectrum (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Incretins in the Therapy of Diabetic Kidney Disease
Agnieszka Przezak, Weronika Bielka, Andrzej Pawlik
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12312-12312
Open Access | Times Cited: 7
Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease
Pamela Houeiss, Rachel Njeim, Hani Tamim, et al.
Journal of Advanced Research (2022) Vol. 44, pp. 109-117
Open Access | Times Cited: 4
Characteristics and Risk of Incident Diabetic Nephropathy between Early-onset versus Late-onset Type 2 Diabetics of Nigerian Origin
Collins Amadi, Johnbosco Okafor, Ochuko Otokunefor, et al.
European Journal of Medical and Health Sciences (2024) Vol. 6, Iss. 6, pp. 60-66
Open Access
circRNAs May Be Involved in Dysfunction of Neutrophils of Type 2 Diabetic Mice through Regulation of Specific miRNAs
Takahiro Umehara, Ryoichi Mori, Kimberly A. Mace, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3129-3129
Open Access | Times Cited: 1
ASSESSING THE LEVEL OF A TRIAL NATRIURETIC PEPTIDE AND SOME BIOCHEMICAL PARAMETERS IN MEN WITH TYPE 2 DIABETIC NEPHROPATHY
Hawraa Yousif AL-Fatlawi, Saher Mahmood Jwad
UTTAR PRADESH JOURNAL OF ZOOLOGY (2022), pp. 1-13
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top